Safety and Efficacy of Cobalt Chromium Everolimus‐Eluting Stents for Treatment of In‐Stent Restenosis: An ILUMIEN IV Substudy
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.039482 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Ziad A Ali und 21 weiteren Autor:innen. Beteiligte Einrichtung: St. Francis Hospital and Heart Center Roslyn NY USA. Hauptthemen laut MEDLINE: Everolimus, Drug-Eluting Stents, Percutaneous Coronary Intervention, Coronary Restenosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The optimal management strategy for in‐stent restenosis (ISR) remains unclear. We aimed to determine the safety and efficacy of percutaneous coronary intervention with XIENCE cobalt chromium everolimus‐eluting stents (EES) for treatment of ISR.
Methods
In the ILUMIEN IV (Optical Coherence Tomography Guided Coronary Stent Implantation Compared to Angiography: A Multicenter Randomized Trial in Percutaneous Coronary Intervention) trial, the 1‐year outcomes of all randomized patients with a single diffuse or multifocal single‐layer ISR lesion treated with EES were compared with a performance goal. The primary end point was target lesion failure, the composite of cardiac death, target vessel‐myocardial infarction, or ischemia‐driven target lesion revascularization. Outcomes in patients with a single EES‐treated ISR and non‐ISR lesion were also compared.
Results
From May 2018 through December 2020, 247 patients with a single ISR lesion were treated with EES. Target lesion failure at 1 year occurred in 18 patients (7.4% [upper 1‐sided 97.5% CI, 11.5%]), which was lower than the predefined performance goal of 20% ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- St. Francis Hospital and Heart Center Roslyn NY USA.
- Clinical Trials Center, Cardiovascular Research Foundation New York NY USA.
- New York Institute of Technology Old Westbury NY USA.
- Department of Cardiology, Angiology and Intensive Care Medicine Deutsches Herzzentrum Charité; Charité - Universitätsmedizin Berlin Berlin Germany.
- Berlin Institute of Health Berlin Germany.
- Deutsches Zentrum für Herz-Kreislaufforschung Partner Site Berlin Germany.
ORCID-Profile: Ziad A Ali, Ulf Landmesser, Akiko Maehara, Doosup Shin, Koshiro Sakai, Mitsuaki Matsumura, Youssef S Abdelwahed, Paolo Canova, Nieves Gonzalo, Fernando Alfonso, Khady N Fall, Robert J McGreevy, Hong Nie, Jin Wang, Gregg W Stone
Zitieren
APA
Ali, Z. A., Landmesser, U., Maehara, A., Shin, D., Sakai, K., Matsumura, M., Shlofmitz, R. A., Calligaris, G., Maksoud, A., Abdelwahed, Y. S., Canova, P., Gonzalo, N., Alfonso, F., Fall, K. N., Chehab, B., McGreevy, R. J., McNutt, R. W., Nie, H., Wang, J., …, & ILUMIEN IV Investigators (2025). Safety and Efficacy of Cobalt Chromium Everolimus‐Eluting Stents for Treatment of In‐Stent Restenosis: An ILUMIEN IV Substudy. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.039482
Vancouver
Ali ZA, Landmesser U, Maehara A, Shin D, Sakai K, Matsumura M, et al. Safety and Efficacy of Cobalt Chromium Everolimus‐Eluting Stents for Treatment of In‐Stent Restenosis: An ILUMIEN IV Substudy. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.039482
BibTeX
@article{Ali2025,
author = {Ali, Ziad A and Landmesser, Ulf and Maehara, Akiko and Shin, Doosup and Sakai, Koshiro and Matsumura, Mitsuaki and Shlofmitz, Richard A and Calligaris, Giuseppe and Maksoud, Aziz and Abdelwahed, Youssef S and Canova, Paolo and Gonzalo, Nieves and Alfonso, Fernando and Fall, Khady N and Chehab, Bassem and McGreevy, Robert J and McNutt, Robert W and Nie, Hong and Wang, Jin and Buccola, Jana and Stone, Gregg W and ILUMIEN IV Investigators, ILUMIEN IV Investigators},
title = {Safety and Efficacy of Cobalt Chromium Everolimus‐Eluting Stents for Treatment of In‐Stent Restenosis: An ILUMIEN IV Substudy},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.039482}
}
EUVIMED